Hip
Senior Member
- Messages
- 18,109
This poll investigates how easily ME/CFS patients sweat after a walk. The answer may relate to a patient's sympathetic nervous system activity, as well as to their immune system competence.
This poll is for ME/CFS patients who are able to do 20 or 30 minute walks at a reasonable pace: do you find you are sweating quite a bit across your torso when you come back home from such walks? Is your shirt, blouse or T-shirt all damp at the end of you walk? Or do you not sweat much at all?
This question assumes you do not live in a very hot and sunny location, which would cause sweating even if you are standing still. Where I live in the UK, summer temperatures are around 20 to 25°C typically (68 to 77°F), and winter temperatures are 5 to 10°C.
I also posted this poll on Reddit ME/CFS, where the poll results indicate a lot of ME/CFS patients have excessive sweating after a walk.
I tend to do a 20 or 30 minute walk once daily were possible, just to get the blood circulating, and for some exercise and fresh air. But when I return home, I find my T-shirt is quite damp with sweat. Not just in the underarm areas: the sweating appears all over my chest and back, so my entire T-shirt is damp. This sweating occurs even in the winter, when it is cold outside and I am dressed up with a jumper and warm coat.
I wonder if other ME/CFS patients perspire a lot from a 20 or 30 minute walk?
I think this sweating from walking might be caused by an overactive sympathetic nervous system (SNS), as this branch of the nervous system controls perspiration, and the medical condition of excess sweating (hyperhidrosis) is known to involve overactivation of the SNS.
For severe cases of hyperhidrosis, a simple surgical operation which cuts the sympathetic nerve in the chest (sympathectomy) is an extremely successful means to permanently cure hyperhidrosis (and can treat Raynaud’s too). Ref: here. So this shows that the SNS is the culprit in excess sweating.
For ME/CFS patients, the significance of having an overactive SNS may be far greater than just the inconvenience of a perspiration-dampened T-shirt: an overactive SNS is generally considered to be immunosuppressive, so having an SNS constantly overactivated may mean you are unable to fully clear viruses from you body.
In particular, the SNS regulates the Th1/Th2 cell balance, and high SNS activation inhibits the Th1 cells which fight viruses and intracellular pathogens, and promotes the Th2 cells which target extracellular bacteria. The paragraphs in the spoiler give the details:
So the above explains that SNS activation inhibits Th1 and promotes Th2. This is achieved by the SNS stimulating the beta-2 adrenergic receptors (β2-AR). Thus for patients with an overactive SNS, selective beta-2 adrenergic receptor blockers may help prevent the Th1 immunosuppressive action of an overactive SNS. However, there are no FDA approved β2-AR blockers, though the research compounds butaxamine and ICI-118,551 are selective β2-AR blockers.
In addition, some POTS patients may have autoantibodies which activate the beta-2 adrenergic receptors. Ref: here
Just a Reminder:
Th1 cytokines: IL-12, IL-2 and IFN-γ
Th2 cytokines: IL-4 and IL-10
Humoral immunity: involves B-cells which make antibodies that target extracellular pathogens like bacteria. Th2 cells help promote humoral immunity.
Cellular immunity: Involves T-cells which target intracellular pathogens like viruses and intracellular bacteria. Th1 cells help promote cellular immunity. This is the type of immunity we need in ME/CFS if we want to clear intracellular viruses.
If ME/CFS patients have constantly high SNS activation, this might explain why Th2-to-Th1 shifters like oxymatrine do not work for them: oxymatrine clears viruses by boosting the Th1 antiviral response; but if the immune system balance is shifted towards Th2 because of an overactivated SNS, this may thwart the action of oxymatrine.
So if SNS activation can be reduced, there may be better viral clearance in ME/CFS patients, and also Th2-to-Th1 shifters like oxymatrine may work better.
➤➤ Drugs That Reduce an Overactive Sympathetic Nervous System
Beta blockers — "β-adrenoceptor antagonists are used widely to reduce cardiovascular sympathetic tone". Ref: here.
Wyller proposed that beta blockers could be used to inhibit sympathetic nervous system activation in ME/CFS. Some beta blockers target both the beta-1 and the beta-2 adrenergic receptors, and activation of the latter mediates the immunosuppressive effects of the SNS on the desirable Th1 immune response (see explanation in the spoiler above). First generation beta blocker like propranolol, sotalol, timolol and nadolol target both beta-1 and beta-2 adrenergic receptors. Ref: here
Prazosin — reduces blood pressure by blocking alpha-1 adrenergic receptors. "As prazosin treatment ameliorates the symptoms of stress, and it also suppresses the sympathetic activity". Ref: here
Doxazosin — reduces blood pressure by blocking alpha-1 adrenergic receptors. It reduces sympathetic activity. Ref: here
Guanfacine — stimulates alpha-2 adrenergic receptors, which in turn reduce sympathetic nerve impulses from the vasomotor centre to the heart and blood vessels. Ref: here
Benicar (olmesartan) possibly — "it is possible, however, that olmesartan affects the brain, thereby inhibiting the sympathetic nervous system, at least in part, by reducing oxidative stress in the autonomic nuclei". Ref: here. So this might offer an alternative explanation of why the Marshall Protocol (which involves taking Benicar) can slowly improve ME/CFS.
Spironolactone — reduces SNS activity via an aldosterone receptor blockade. Ref: here. This might explain why spironolactone treatment can lead to substantial improvements in EBV ME/CFS.
Clonidine — "in the medulla, clonidine, acting as an alpha-antagonist, inhibits excitatory input to the sympathetic nervous system". Ref: here
Calcium channel blockers diltiazem, nifedipine and verapamil — "may selectively reduce low level (or basal) sympathetic neurotransmission". Ref: here
➤➤ Factors Which Increase Sympathetic Nervous System Activity
Magnesium deficiency — induces sympathetic excitation. Ref: here
Psychological stress — well-known to activate the fight or flight response, which include SNS activation.
LPS (lipopolysaccharide) — "systemic injection of LPS also activates the sympathetic nervous system". Ref: here. A study showed many ME/CFS patients have high levels of LPS, perhaps leaking into the bloodstream from the gut.
This poll is for ME/CFS patients who are able to do 20 or 30 minute walks at a reasonable pace: do you find you are sweating quite a bit across your torso when you come back home from such walks? Is your shirt, blouse or T-shirt all damp at the end of you walk? Or do you not sweat much at all?
This question assumes you do not live in a very hot and sunny location, which would cause sweating even if you are standing still. Where I live in the UK, summer temperatures are around 20 to 25°C typically (68 to 77°F), and winter temperatures are 5 to 10°C.
I also posted this poll on Reddit ME/CFS, where the poll results indicate a lot of ME/CFS patients have excessive sweating after a walk.
I tend to do a 20 or 30 minute walk once daily were possible, just to get the blood circulating, and for some exercise and fresh air. But when I return home, I find my T-shirt is quite damp with sweat. Not just in the underarm areas: the sweating appears all over my chest and back, so my entire T-shirt is damp. This sweating occurs even in the winter, when it is cold outside and I am dressed up with a jumper and warm coat.
I wonder if other ME/CFS patients perspire a lot from a 20 or 30 minute walk?
I think this sweating from walking might be caused by an overactive sympathetic nervous system (SNS), as this branch of the nervous system controls perspiration, and the medical condition of excess sweating (hyperhidrosis) is known to involve overactivation of the SNS.
For severe cases of hyperhidrosis, a simple surgical operation which cuts the sympathetic nerve in the chest (sympathectomy) is an extremely successful means to permanently cure hyperhidrosis (and can treat Raynaud’s too). Ref: here. So this shows that the SNS is the culprit in excess sweating.
For ME/CFS patients, the significance of having an overactive SNS may be far greater than just the inconvenience of a perspiration-dampened T-shirt: an overactive SNS is generally considered to be immunosuppressive, so having an SNS constantly overactivated may mean you are unable to fully clear viruses from you body.
In particular, the SNS regulates the Th1/Th2 cell balance, and high SNS activation inhibits the Th1 cells which fight viruses and intracellular pathogens, and promotes the Th2 cells which target extracellular bacteria. The paragraphs in the spoiler give the details:
SNS regulation of Th1 and Th2 cell differentiation
The SNS regulates the differentiation of Th cells, including autoreactive cells, through the activation of α- and β2-ARs expressed on their cell surfaces. Sympathetic nerves are present adjacent to target immune cells in secondary LOs [lymphoid organs] and the immune cell infiltrates in the tertiary lymph nodules that occur in the affected joints.
In secondary LOs, NE [norepinephrine] released from sympathetic nerves activates β2-ARs [β2-adrenergic receptors] expressed in T cells. This receptor activation inhibits IL-2 production, which subsequently suppresses lymphocyte proliferation required for clonal expansion.
Activation of β2-ARs on Th0/Th1 cells also inhibits cellular and promotes humoral immunity by regulating the phenotypic differentiation of CD4+ Th cells in response to challenge with T cell-dependent antigens. β2-AR stimulation inhibits IFN-γ production by receptor coupling to Gs protein, increased intracellular cAMP production and subsequent phosphorylation of PKA. Reduced IFN-γ limits Th0 cell differentiation towards the Th1 phenotype, and dampens IFN-γ-mediated inhibition of IL-4 production, promoting IL-4 synthesis by Th2 cells.
In this manner, the SNS provides a negative feedback mechanism to restore immune system homeostasis after antigen challenges that activate cellular immunity. Additionally, β2-ARs preferentially inhibit IL-12 and increase IL-10 production by APCs, which subsequently promotes Th2 and inhibits Th1 differentiation.
Source: Sympathetic Nervous System Regulation of Th Cells in Autoimmunity: Beyond Th1 and Th2 Cell Balance.
So the above explains that SNS activation inhibits Th1 and promotes Th2. This is achieved by the SNS stimulating the beta-2 adrenergic receptors (β2-AR). Thus for patients with an overactive SNS, selective beta-2 adrenergic receptor blockers may help prevent the Th1 immunosuppressive action of an overactive SNS. However, there are no FDA approved β2-AR blockers, though the research compounds butaxamine and ICI-118,551 are selective β2-AR blockers.
In addition, some POTS patients may have autoantibodies which activate the beta-2 adrenergic receptors. Ref: here
Just a Reminder:
Th1 cytokines: IL-12, IL-2 and IFN-γ
Th2 cytokines: IL-4 and IL-10
Humoral immunity: involves B-cells which make antibodies that target extracellular pathogens like bacteria. Th2 cells help promote humoral immunity.
Cellular immunity: Involves T-cells which target intracellular pathogens like viruses and intracellular bacteria. Th1 cells help promote cellular immunity. This is the type of immunity we need in ME/CFS if we want to clear intracellular viruses.
If ME/CFS patients have constantly high SNS activation, this might explain why Th2-to-Th1 shifters like oxymatrine do not work for them: oxymatrine clears viruses by boosting the Th1 antiviral response; but if the immune system balance is shifted towards Th2 because of an overactivated SNS, this may thwart the action of oxymatrine.
So if SNS activation can be reduced, there may be better viral clearance in ME/CFS patients, and also Th2-to-Th1 shifters like oxymatrine may work better.
➤➤ Drugs That Reduce an Overactive Sympathetic Nervous System
Beta blockers — "β-adrenoceptor antagonists are used widely to reduce cardiovascular sympathetic tone". Ref: here.
Wyller proposed that beta blockers could be used to inhibit sympathetic nervous system activation in ME/CFS. Some beta blockers target both the beta-1 and the beta-2 adrenergic receptors, and activation of the latter mediates the immunosuppressive effects of the SNS on the desirable Th1 immune response (see explanation in the spoiler above). First generation beta blocker like propranolol, sotalol, timolol and nadolol target both beta-1 and beta-2 adrenergic receptors. Ref: here
Prazosin — reduces blood pressure by blocking alpha-1 adrenergic receptors. "As prazosin treatment ameliorates the symptoms of stress, and it also suppresses the sympathetic activity". Ref: here
Doxazosin — reduces blood pressure by blocking alpha-1 adrenergic receptors. It reduces sympathetic activity. Ref: here
Guanfacine — stimulates alpha-2 adrenergic receptors, which in turn reduce sympathetic nerve impulses from the vasomotor centre to the heart and blood vessels. Ref: here
Benicar (olmesartan) possibly — "it is possible, however, that olmesartan affects the brain, thereby inhibiting the sympathetic nervous system, at least in part, by reducing oxidative stress in the autonomic nuclei". Ref: here. So this might offer an alternative explanation of why the Marshall Protocol (which involves taking Benicar) can slowly improve ME/CFS.
Spironolactone — reduces SNS activity via an aldosterone receptor blockade. Ref: here. This might explain why spironolactone treatment can lead to substantial improvements in EBV ME/CFS.
Clonidine — "in the medulla, clonidine, acting as an alpha-antagonist, inhibits excitatory input to the sympathetic nervous system". Ref: here
Calcium channel blockers diltiazem, nifedipine and verapamil — "may selectively reduce low level (or basal) sympathetic neurotransmission". Ref: here
➤➤ Factors Which Increase Sympathetic Nervous System Activity
Magnesium deficiency — induces sympathetic excitation. Ref: here
Psychological stress — well-known to activate the fight or flight response, which include SNS activation.
LPS (lipopolysaccharide) — "systemic injection of LPS also activates the sympathetic nervous system". Ref: here. A study showed many ME/CFS patients have high levels of LPS, perhaps leaking into the bloodstream from the gut.
Last edited: